Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis.
cellular malignancy
head and neck cancer
hexokinase 2
metabolic shift
therapeutic efficacy
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
11
2019
accepted:
31
01
2020
entrez:
21
3
2020
pubmed:
21
3
2020
medline:
21
3
2020
Statut:
epublish
Résumé
To support great demand of cell growth, cancer cells preferentially obtain energy and biomacromolecules by glycolysis over mitochondrial oxidative phosphorylation (OxPhos). Among all glycolytic enzymes, hexokinase (HK), a rate-limiting enzyme at the first step of glycolysis to catalyze cellular glucose into glucose-6-phosphate, is herein emphasized. Four HK isoforms, HK1-HK4, were discovered in nature. It was shown that HK2 expression is enriched in many tumor cells and correlated with poorer survival rates in most neoplastic cells. HK2-mediated regulations for cell malignancy and mechanistic cues in regulating head and neck tumorigenesis, however, are not fully elucidated. Cellular malignancy index, such as cell growth, cellular motility, and treatment sensitivity, and molecular alterations were determined in HK2-deficient head and neck squamous cell carcinoma (HNSCC) cells. By using various cancer databases, HK2, but not HK1, positively correlates with HNSCC progression in a stage-dependent manner. A high HK2 expression was detected in head and neck cancerous tissues compared with their normal counterparts, both in mouse and human subjects. Loss of HK2 in HNSCC cells resulted in reduced cell (
Identifiants
pubmed: 32195170
doi: 10.3389/fonc.2020.00176
pmc: PMC7063098
doi:
Types de publication
Journal Article
Langues
eng
Pagination
176Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2020 Li, Huang, Hsieh, Chen, Cheng, Chen, Liu, Chen, Huang, Lo and Chang.
Références
Autophagy. 2018;14(4):671-684
pubmed: 28980855
Int J Biochem Cell Biol. 2018 Feb;95:9-16
pubmed: 29247711
Oncotarget. 2016 Jul 5;7(27):41798-41810
pubmed: 27260001
Carcinogenesis. 2017 Feb 1;38(2):119-133
pubmed: 27993896
J Biol Chem. 1988 Nov 25;263(33):17422-8
pubmed: 3182854
Oncol Rep. 2015 Mar;33(3):1533-9
pubmed: 25591943
Tumour Biol. 2014 Apr;35(4):3743-53
pubmed: 24363061
Cancer Biomark. 2016 Jun 7;17(1):75-81
pubmed: 27314295
Nat Commun. 2018 Jan 31;9(1):446
pubmed: 29386513
Int J Clin Exp Pathol. 2015 Apr 01;8(4):4054-63
pubmed: 26097593
Pharmacol Res. 2019 Dec;150:104511
pubmed: 31678210
Biochem Biophys Res Commun. 2016 Jan 1;469(1):37-43
pubmed: 26607110
Exp Cell Res. 2016 Dec 10;349(2):320-327
pubmed: 27829129
ACS Med Chem Lett. 2015 Dec 28;7(3):217-22
pubmed: 26985301
Br J Cancer. 2016 Mar 29;114(7):759-66
pubmed: 26986252
Biochem Biophys Res Commun. 2016 Apr 22;473(1):147-153
pubmed: 27012210
Neoplasia. 2019 Jul;21(7):641-652
pubmed: 31100640
Oncotarget. 2015 May 30;6(15):13703-17
pubmed: 25938543
Oncotarget. 2015 Oct 6;6(30):29268-84
pubmed: 26337468
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
Cancer Metab. 2016 Aug 18;4:16
pubmed: 27540483
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Int J Oncol. 2015 Feb;46(2):775-81
pubmed: 25405516
Nature. 2002 Jan 31;415(6871):530-6
pubmed: 11823860
Mitochondrion. 2016 Sep;30:222-8
pubmed: 27544294
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
Sci Rep. 2015 Mar 12;5:9065
pubmed: 25761777
J Exp Med. 2011 Feb 14;208(2):313-26
pubmed: 21242296
Int J Mol Sci. 2019 Aug 14;20(16):
pubmed: 31416244
Cancer Cell Int. 2016 May 24;16:38
pubmed: 27222636
Mol Cell Biochem. 1974 Nov 15;5(1-2):17-23
pubmed: 4279327
Database (Oxford). 2017 Jan 6;2017:
pubmed: 28062517
J Cell Biochem. 2018 Jun;119(6):4967-4974
pubmed: 29384225
Cancer Sci. 2014 Aug;105(8):951-5
pubmed: 24890811
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9268-73
pubmed: 19470470
J Surg Res. 2013 May;181(2):262-71
pubmed: 23510551
Tumour Biol. 2015 Jan;36(1):383-91
pubmed: 25266796
Oncogene. 2006 Aug 7;25(34):4777-86
pubmed: 16892090
EMBO J. 2012 Apr 18;31(8):1985-98
pubmed: 22354042
Cell Death Discov. 2017 Jan 23;3:16103
pubmed: 28179998
Nat Rev Cancer. 2018 Feb;18(2):128-134
pubmed: 29326430
Int J Mol Med. 2018 Oct;42(4):2247-2259
pubmed: 30015920
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Mol Carcinog. 2017 Feb;56(2):694-711
pubmed: 27380877
J Exp Med. 2012 Feb 13;209(2):211-5
pubmed: 22330683
Hepatology. 2015 Oct;62(4):1132-44
pubmed: 26054020
Molecules. 2016 Dec 15;21(12):
pubmed: 27983708
Clin Cancer Res. 2005 Jun 1;11(11):4241-50
pubmed: 15930363
Biochem Biophys Res Commun. 2014 Apr 25;447(1):184-91
pubmed: 24704448
Med Hypotheses. 2009 Jul;73(1):48-51
pubmed: 19264418
Cancer Sci. 2013 Dec;104(12):1567-74
pubmed: 24033605
Cell Rep. 2014 Sep 11;8(5):1461-74
pubmed: 25176644
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Mol Cell Biol. 2008 Oct;28(20):6462-72
pubmed: 18710949
J Nucl Med. 2014 Dec;55(12):2038-44
pubmed: 25453050
Oncol Lett. 2019 Sep;18(3):2212-2219
pubmed: 31452722
Mol Cancer Res. 2009 Sep;7(9):1438-45
pubmed: 19723875
Cancer Metab. 2013 Jun 11;1(1):15
pubmed: 24280296
Diagnostics (Basel). 2013 Oct 29;3(4):372-84
pubmed: 26824929
Nat Rev Drug Discov. 2011 Aug 31;10(9):671-84
pubmed: 21878982
Eur J Gynaecol Oncol. 2014;35(5):519-24
pubmed: 25423696
Biochem Biophys Res Commun. 2017 Aug 19;490(2):217-224
pubmed: 28602700
Int J Cancer. 2019 Oct 15;145(8):2144-2156
pubmed: 30920655
Oncology. 2004;67(2):143-50
pubmed: 15539919
EMBO Mol Med. 2013 May;5(5):707-22
pubmed: 23610071
Oncol Rep. 2013 Dec;30(6):2829-37
pubmed: 24100418
Oncotarget. 2017 Apr 11;8(15):24777-24784
pubmed: 28445971
Genes Dev. 2012 May 1;26(9):877-90
pubmed: 22549953
Mol Cell Proteomics. 2019 Nov;18(11):2273-2284
pubmed: 31519767
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
PLoS One. 2012;7(10):e46591
pubmed: 23071593
Health Technol Assess. 2010 Jul;14(37):1-288
pubmed: 20663420
J Cell Physiol. 2013 Sep;228(9):1943-8
pubmed: 23629924
J Exp Biol. 2003 Jun;206(Pt 12):2049-57
pubmed: 12756287
Cell Rep. 2019 Aug 13;28(7):1845-1859.e5
pubmed: 31412251
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20491-6
pubmed: 23185017
Br J Pharmacol. 2014 Dec;171(24):5507-23
pubmed: 24665826
J Exp Clin Cancer Res. 2017 Apr 20;36(1):58
pubmed: 28427443
Oncotarget. 2017 May 9;8(19):32332-32344
pubmed: 28415659
Mol Clin Oncol. 2015 May;3(3):563-571
pubmed: 26137268
PLoS One. 2016 Nov 8;11(11):e0166230
pubmed: 27824926
Cell Death Differ. 2015 Feb;22(2):248-57
pubmed: 25323588
BMC Cancer. 2012 Jun 12;12:232
pubmed: 22691140
Cancer Res. 2016 Mar 15;76(6):1615-26
pubmed: 26795347
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683